Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma

RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma

US Patent 8173617 · Granted May 8, 2012

Estimated economic value: $5,572,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)2023
Devices, systems, and methods for modeling ocular translaminar pressure gradient2023
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)2022
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)2022
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)2021
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)2021
Transferrin/transferrin receptor-mediated siRNA delivery2018
Transferrin/transferrin receptor-mediated siRNA delivery2018
Interfering RNA delivery system and uses thereof2018
Interfering RNA delivery system and uses thereof2017
RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of CAMP-relat2017
RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions2017